June 25, 2024

Medical Foods Market Size to Worth USD 38.90 Billion By 2033

The global medical foods market size accounted for USD 23.59 billion in 2023 and is predicted to attain around USD 38.90 billion by 2033, growing at a CAGR of 5.13% from 2024 to 2033.

Key Points

  • The North America medical foods market size accounted for USD 7.75 billion in 2023 and is expected to rise around USD 12.45 billion by 2033.
  • North America led the global market with a major market share of 32% in 2023.
  • Asia Pacific will be the fastest-growing region in the global market during the projected period.
  • By route of administration, the oral segment has generated more than 71% of market share in 2023.
  • By route of administration, the enteral segment is expected to witness the fastest growth over the forecast years.
  • By product type, the powder segment accounted for the largest market share in 2023.
  • By product type, the liquid segment is anticipated to grow at the fastest rate during the forecast period.
  • By application, the cancer segment has held the largest market share in 2023.
  • By sales channels, the institutional sales channel segment has captured more By sales channels, the online sales segment will be the fastest-growing segment during the forecast period.

Medical Foods Market Size 2024 to 2033

The global medical foods market is witnessing significant growth driven by increasing awareness about the role of nutrition in managing specific medical conditions. Medical foods are specialized formulations intended for dietary management of diseases and health conditions under medical supervision. These products are distinct from conventional foods and dietary supplements due to their therapeutic benefits and targeted nutritional composition. The market encompasses a diverse range of products tailored to address various health challenges, ranging from metabolic disorders to neurological conditions.

Get a Sample: https://www.precedenceresearch.com/sample/4244

Growth Factors

Several factors contribute to the growth of the medical foods market. The rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and neurodegenerative diseases has heightened the demand for therapeutic nutrition solutions. Moreover, advancements in medical research and understanding of nutritional science have led to the development of innovative medical food formulations targeting specific disease pathways and metabolic processes. Additionally, increasing healthcare expenditure and growing adoption of personalized nutrition are driving market expansion globally.

Region Insights

The market for medical foods exhibits regional variations based on disease prevalence, regulatory landscape, and consumer awareness. North America holds a prominent share due to a well-established healthcare infrastructure and high consumer awareness about disease management through nutrition. In Europe, stringent regulations and a growing aging population contribute to market growth. Emerging economies in Asia-Pacific show promising growth potential driven by rising healthcare investments and increasing incidence of lifestyle-related diseases.

Medical Foods Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 5.13%
Global Market Size in 2023 USD 23.59 Billion
Global Market Size in 2024 USD 24.80 Billion
Global Market Size by 2033 USD 38.90 Billion
Largest Market North America
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Route of Administration, By Product, By Application, and By Sales Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Medical Foods Market Dynamics

Drivers

Key drivers fueling the medical foods market include the growing aging population worldwide, which is more susceptible to chronic diseases requiring specialized nutrition. Additionally, the emphasis on preventive healthcare and wellness initiatives is encouraging the adoption of medical foods as part of disease management strategies. Technological advancements in food science and formulation techniques are enabling the development of efficacious and palatable medical food products, further driving market acceptance and demand.

Opportunities

The medical foods market presents significant opportunities for innovation and market expansion. Collaborations between healthcare professionals, food scientists, and nutritionists can lead to the development of tailored medical food solutions for specific patient populations. Targeting niche segments such as pediatric nutrition, sports nutrition, and oncology-related nutrition offers untapped growth potential. Moreover, expanding distribution channels and increasing consumer education about the benefits of medical foods can enhance market penetration and adoption.

Challenges

Despite growth prospects, the medical foods market faces challenges such as regulatory complexities surrounding product labeling, claims, and market authorization. Limited reimbursement policies for medical foods in some regions pose a barrier to market accessibility and affordability. Moreover, ensuring compliance with quality standards and maintaining product efficacy throughout the supply chain presents operational challenges for manufacturers and distributors in the medical foods industry.

Read Also: Infertility Drugs Market Size to Attain USD 6.73 Bn By 2033

Medical Foods Market Recent Developments

  • In July 2022, Nestle launched the first Food for Medical Purpose (FSMP) for cancer patients suffering from tumor conditions. The product was called Oral Impact Su Yi Su. It took five years to approve this product. It contains arginine, fish oil omega-3, and nucleotide on top of other ingredients. The product was designed to address the problem of inflammation and compromised immunity.

Medical Foods Market Companies

  • Danone
  • Nestlé
  • Abbott
  • Targeted Medical Pharma Inc.
  • Primus Pharmaceuticals Inc.
  • Fresenius Kabi AG
  • Mead Johnson & Company, LLC

Segments Covered in the Report

By Route of Administration

  • Oral
  • Enteral

By Product

  • Powder
  • Pills
  • Liquid
  • Other

By Application

  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy-induced Diarrhoea
  • Pathogen-related Infections
  • Diabetic Neuropathy
  • Adhd
  • Depression
  • Alzheimer’s Disease
  • Nutritional Deficiency
  • Orphan Diseases
    • Tyrosinemia
    • Eosinophilic esophagitis
    • Fpies
    • Phenylketonuria
    • Msud
    • Homocystinuria
    • Others
  • Wound Healing
  • Chronic Diarrhea
  • Constipation Relief
  • Protein Booster
  • Dysphagia
  • Pain Management
  • Parkinson’s Disease
  • Epilepsy
  • Other cancer-related Treatments
  • Severe protein Allergy
  • Cancer
  • Cachexia
  • Other

By Sales Channel

  • Online Sales
  • Retail Sales
  • Institutional Sales

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/


Prathamesh

Leave a Reply

Your email address will not be published. Required fields are marked *